NASDAQ: VKTX · Health Care / Biotechnology: Pharmaceutical Preparations

Viking Therapeutics Inc.

How Viking Therapeutics Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$3.4B

Price

$26.86

P/E

-5.5

EPS (TTM)

$-4.92

1-year return

-23.7%

Dividend yield

0.0%

52-week range

$24.21–$34.27

Compared with

• Biotechnology: Pharmaceutical Preparations industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources